Year: 2024

More news - Latest news In 2020, Kristina Knighten, 38, and her husband Paul Cordier, 46, finalized the purchase of their picturesque home overlooking Lake Iseo in Italy. They purchased this charming two-bedroom residence for €23,000 (approximately $24,973 USD). Describing their new home, Knighten shares with CNBC Make It, "It's the kind of house you picture as a kid, complete with a gable roof, center door, and quaint upstairs windows. It's ideally located, just steps from both the train station and the lake, and it almost seems too good to be true." The duo began the renovation in March this…

More news - Latest news Mauricio Pochettino, known for his attacking, high-pressing style, is set to take the reins of the United States men’s national team. The U.S. Soccer Federation has made a bold statement by securing the services of Mauricio Pochettino as its new manager. The Argentine tactician, celebrated for his work at Tottenham Hotspur and Paris Saint-Germain, brings a wealth of experience and a proven track record of success. Pochettino’s appointment is undoubtedly a stroke of luck for U.S. soccer. The former defender has built a reputation as one of Europe’s most exciting and innovative coaches. His ability…

Related media - Latest news Airwallex, a Tencent-backed fintech startup recently valued at $5.5 billion, has reached a significant financial milestone by hitting $500 million in annual revenue. The company’s CEO and co-founder Jack Zhang revealed in a recent discussion that Airwallex is targeting an initial public offering (IPO) by 2026. During the interview, Zhang expressed optimism that the company’s annual recurring revenue will potentially double to $1 billion by 2027. Airwallex’s growth trajectory has been steep, supported by strategic expansions in key markets in the UK, Europe and North America. These regions now contribute more than 35% of the…

Related media - Recent news Three research papers exploring MDMA-assisted therapy for PTSD have been retracted by the journal Psychopharmacology. This follows the recent rejection of MDMA for this use by the Food and Drug Administration (FDA). The retracted studies, written by researchers affiliated with Lykos Therapeutics, the company behind the rejected treatment application, were found to involve unethical conduct at one of the research sites. Lykos, however, maintains that the retracted research was not part of their submission to the FDA. This development adds another layer of complexity to the ongoing debate over MDMA-assisted therapy. While some research suggests…